MedTrace Logo

A Pilot Study - Safety and Efficacy of Nailprotex® for Onychomycosis Treatment

NCT02464826 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2016-06-17

No results posted yet for this study

Summary

This study was designed to demonstrate the efficacy of this product in non-dermatophyte (Scytalidium dimidiatum) onychomycosis and chronic paronychia treatment in Thai patients.

Conditions

  • Onychomycosis
  • Chronic Paronychia

Interventions

DRUG

Nailprotex

Nailprotex apply to the abnormal nail twice daily

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Charussri - Leeyaphan, MD. · Department of Dermatology Faculty of Medicine, Siriraj Hospital Mahidol University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • Thailand

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02464826 on ClinicalTrials.gov